Clinical trials
Phase 2 Iron Overload trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2005 | 2 |
| 2007 | 2 |
| 2011 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 6 |
| Recruiting | 1 |
| Terminated | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 4 |
| Abfero Pharmaceuticals, Inc | 1 |
| Andrea Kew | 1 |
| ApoPharma | 1 |
| CSL Behring | 1 |
| Shire | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Iron Overload | 9 |
| Anemia, Sickle Cell | 2 |
| Hemochromatosis | 2 |
| Myelodysplastic Syndromes | 2 |
| beta-Thalassemia | 2 |
| Anemia | 1 |
| Anemia, Diamond-Blackfan | 1 |
| Anemia, Hemolytic | 1 |
| Anemia, Sideroblastic | 1 |
| Hemosiderosis | 1 |
Trials
Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.